CoChat

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Open access
Ionescu, Dawn F, Luckenbaugh, David A, Niciu, Mark J, Richards, Erica M, Zarate, Carlos A · 2015 · Bipolar Disorders
Cited by 104

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: Patents with anxious bipolar disorder have worse clinical outcomes and are harder to treat with traditional medication regimens compared to those with non‐anxious bipolar disorder. Ketamine has been shown to rapidly and robustly decrease symptoms of depression in depressed patients with bipolar disorder. We sought to determine whether baseline anxiety status reduced ketamine's ability to decrease symptoms of depression. Methods: Thirty‐six patients with anxious (n = 21) and non‐anxious (n = 15) treatment‐resistant bipolar depression (types I and II; concurrently treated with either lithium or valproate) received a single infusion of ketamine (0.5 mg/kg) over 40 min. Post‐hoc analyses compared changes in the Montgomery–Åsberg Depression Rating Scale (MADRS) and Hamilton Depression Rating Scale (HDRS) in anxious versus non‐anxious depressed patients with bipolar disorder through 14 days post‐infusion. Anxious bipolar depression was defined as DSM‐IV bipolar depression plus a HDRS Anxiety/Somatization Factor score of ≥ 7. Results: A linear mixed model revealed a significant effect of anxiety group on the MADRS (p = 0.04) and HDRS (p = 0.04). Significant drug effects (all p < 0.001) suggested that both anxious and non‐anxious groups had an antidepressant response to ketamine. The drug‐by‐anxiety interactions were not significant (all p > 0.28). Conclusions: Both anxious and non‐anxious patients with bipolar depression had significant antidepressant responses to ketamine, although the anxious depressed group did not show a clear antidepressant response disadvantage over the non‐anxious group. Given that anxiety has been shown to be a predictor of poor treatment response in bipolar depression when traditional treatments are used, our findings suggest a need for further investigations into ketamine's novel role in the treatment of anxious bipolar depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bdi.12277

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 16

  1. 10.1176/appi.books.9780890425596 · DOI · Paper page
  2. 10.1007/s11126-008-9071-5 · DOI
  3. 10.2147/DDDT.S63779 · DOI · Paper page
  4. 10.1016/j.jad.2007.03.014 · DOI · Paper page
  5. 10.1176/appi.ajp.2013.13070984 · DOI · Paper page
  6. 10.1176/appi.ajp.2013.13070985 · DOI · Paper page
  7. 10.1016/j.jad.2011.12.001 · DOI
  8. First MB, 1997, Structured Clinical Interview for DSM‐IV Axis I Disorders (SCID I)
  9. 10.1192/bjp.134.4.382 · DOI · Paper page
  10. Cleary P, 1977, Factor analysis of Hamilton Depression Scale, Drugs Exp Clin Res, 1, 115
  11. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  12. American Psychiatric Association, 2000, Task Force on DSM‐IV. Diagnostic and Statistical Manual of Mental Disorders: DSM‐IV‐TR
  13. 10.1002/mpr.353 · DOI · Paper page
  14. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  15. 10.1176/appi.ajp.2014.13101434 · DOI
  16. 10.4088/JCP.13m08961 · DOI · Paper page

Cited by

See all 104

Metadata

Authors
Ionescu, D. F., Luckenbaugh, D. A., Niciu, M. J., Richards, E. M., & Zarate, C. A.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2014-11-14
Volume
17
Issue
4
Pages
438-443
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2043085142
Cited by
104
References
10
FWCI
4.11
Type
journal article
Language
en
Open access
hybrid
Funders
  • NARSAD (Independent Investigator to CAZ)
  • National Institute of Mental Health (Intramural Research Program to CAZ)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.